Search results for: stepping-address-stimulants

> Back to Focus on Stimulants Page   The ATTC Network proudly presents a core curriculum training package to provide information about central nervous system stimulants and their impact on...

Training for Stepping Stones in AK

This series is a sequence of three cumulative two-hour virtual sessions regarding stimulants, consumption, and community impact. The two-hour webinars will inform on the prevalence of stimulant use, define stimulant use disorder and related challenges, and recommended strategies for treatment. Participants may join any or all sessions in the series. You must register for each course separately. Course 1: Stimulants – What are they? Who uses them? This virtual session will provide an epidemiological review of cocaine and methamphetamine, and other prescribed stimulants. The content will review the mental and physical health impact of stimulant use, prevalence rates, communities impacted and medical consequences of use such as HIV. Credits: Each session meets the requirements for two renewal hours (CASAC, CPP, CPS) and two initial hours (CPP, CPS) through New York State’s Office of Addiction Services and Supports (NYS OASAS). As an IC & RC member board, OASAS accredited courses are granted reciprocal approval by the New Jersey Division of Consumer Affairs, Alcohol and Drug Counselor Committee.

According to the 2019 National Survey on Drug Use and Health, almost 10% of people aged 12 or older in Region 8 (Colorado, Montana, North Dakota, South Dakota, Utah, and Wyoming) had a substance use disorder in the past year, which is higher than the national average. In addition, data from this survey show that 403,000 people in the Region had an illicit drug use disorder, with stimulants, opioids, and cannabis named as three of the major illicit drugs used. Certainly, stimulant use (especially methamphetamine) rates are increasing nationally as well as in Region 8. A recent study by Jones, Compton, and Mustaquim (2020) found that 1.6 million adults (over 18) reported past-year use of methamphetamine; over a quarter reported using methamphetamine on more than 200 days; over half had a methamphetamine use disorder; and over 1/5 had injected methamphetamine. In response to these stimulant use trends, representatives from the regional Addiction Technology Transfer Centers (ATTCs), led by the ATTC Network Coordinating Office, created a day-long curriculum titled <i> Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery. </i> Due to the Public Health Emergency (PHE), this day-long curriculum was re-packaged into a three-part webinar series by the ATTC Stimulant Workgroup. The MPATTC is pleased to sponsor the following events:   Part 1: Stimulants: What Are They and Who Uses Them?, March 9, 2021 Part 2: Impact of Stimulant Use on the Brain and Body, March 16, 2021 Part 3: Effective Treatment Approaches and Recovery Supports, March 23, 2021   All three webinars will be offered at 12:00 pm Mountain and 1:00pm Central for 1.5 hours. Participants can attend one, two, or all three webinars. CEUs will be provided for each webinar and certificates indicating attendance will be sent out after the last webinar.

...organized by year.  You can also browse webinars by topic: Substances: Cannabis | Opioids | Stimulants Treatment:  General/Miscellaneous | Integration | Medication/Pharmacotherapy | Trauma-informed Harm reduction HIV and/or Hepatitis C Mi

A new report from Centers for Disease Control and Prevention indicates that overdose deaths involving cocaine and psychostimulants continue to increase.   This report underscores the need for comprehensive, evidence-based public health...

...strategies for facing addiction in America. Please join Dr. Clark on the   webinar! This SG Report proposes a comprehensive and widely-applicable framework for addressing substance use, misuse, and dependence in America....

The New England ATTC in partnership with the Connecticut Department of Mental Health and Addictions Services is hosting the Coming into the Light: Breaking the Stigma of Substance Use Disorders training on 4/21/22 from 9:00-2:30 (EST) with subject matter expert Taylor D'Addario. Stigma is a major barrier preventing millions of people who are struggling with substance use from entering treatment today.  This presentation is designed to help professionals break that stigma that creates an unnecessary barrier to treatment by understanding recovery oriented language and strategies that can be integrated into practice immediately. [This event is private and by invitation only]

The New England ATTC in partnership with the Connecticut Department of Mental Health and Addictions Services is hosting the Stimulants and their Impact on Brain and Behavior training on 11/17/21 and 11/18/21 from 9:00-12:00 (EST).  The purpose of this introductory level training is to provide information about central nervous system stimulants and their impact on brain, body, and behavior.  Specific topics include (1) the scope of stimulant use in the US and beyond; (2) impact of stimulants on cognition; (3) stimulant use and psychosis; (4) short- and long-term physical and mental health consequences of stimulant use and considerations for unique populations; (5) the intersection of stimulant use and HIV risk; and (6) effective evidence-based behavioral treatment interventions and recovery supports for people with a stimulant use disorder.    [This event is private and by invitation only]

Description: This 3-hour live virtual training will provide participants with introductory level instruction on stimulant use disorders. The training is intended for any clinicians and administrators who provide care to people who use central nervous system stimulants. The training will be divided into three sections. Part 1 will focus on Stimulants – What are they and who uses them?; Part 2 will focus on the Impact of Stimulant Use on the Brain and Body; and Part 3 will focus on Effective Treatment Approaches and Recovery Supports. Specific topics will include: (1) the scope of stimulant use in the United States and beyond; (2) stimulants and the brain and their impact on cognition; (3) acute and chronic physical and psychological effects of cocaine and methamphetamine; and (4) effective evidence-based behavioral treatments and recovery approaches for people with a stimulant use disorder. At the end of the training, participants will be able to:   Identify three (3) specific national patterns and trends in stimulant use. Recall the three (3) manufacturing processes for methamphetamine. Specify at least three (3) key differences between cocaine and methamphetamine. Specify two (2) examples of the cognitive impact associated with stimulant use. Recall three (3) ways stimulants physically impact the body. Identify at least two (2) factors that increase the risk of violence among people who use stimulants. Apply at least two (2) specific behavioral treatment interventions and two recovery approaches that have been proven effective in treating people with a stimulant use disorder. Specify at least two (2) ways that physical exercise affects stimulant use. Recall two (2) definitions of recovery.

The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.     This three-hour stimulant training developed by the ATTC Network stimulants workgroup provides an overview of the impact of stimulant drugs on the brain and body. The training includes current data on national and regional trends in stimulant use.     LEARNING OBJECTIVES Review national and regional trends in stimulant use Learn about the impact of stimulants se on the brain and body Understand current best practices in treatment for stimulant use disorders     CONTINUING EDUCATION Three NAADAC CE hours will be awarded to participants who attend all three sessions in full. Certificates will be emailed shortly after the conclusion of the final session. Partial credit will not be awarded.     TRAINING SCHEDULE All three training sessions will be held from 9:00 AM – 10:00 AM Central.  November 10, 2021   November 17 2021 November 24, 2021  (SKIP) December 1, 2021     PRESENTER   Mat Roosa, LCSW-R Mat Roosa was a founding member of NIATx and has been a NIATx coach for a wide range of projects. He works as a consultant in the areas of quality improvement, organizational development, and planning, evidence-based practice implementation. His experience includes direct clinical practice in mental health and substance use services, teaching at the undergraduate and graduate levels, and human service agency administration.      

The Impact of Stimulants and Fentanyl on Brain, Body, and Behavior and Effective Treatment and Overdose Prevention Approaches Presented by Beth Rutkowski, MPH   Thursday, December 7th, 20238:00AM - 2:30PM HST Location: In-Person UH Mānoa Campus Center Dining room 203E 2465 Campus Rd, Honolulu, HI 96822 Parking available on campus at the lower campus parking garage for $5.00.   At the end of this webinar, participants will be able to: Identify three (3) specific patterns and trends in stimulant and fentanyl use in the United States. Recall at least three (3) acute and chronic effects of stimulants and fentanyl. Explain at least two (2) specific behavioral treatment interventions proven to be effective in treating people with a stimulant use disorder. Describe two (2) medical and two (2) behavioral treatment interventions proven to be effective in treating people with an opioid use disorder. Explain three (3) overdose prevention tools or strategies. Hawaiʻi SUPD trainings are held in conjunction with the Thompson School of Social Work & Public Health Continuing Education and Professional Development (CEPD) Program. Space is limited. Priority for this training will be given to those in the process of obtaining or renewing an ADAD Substance Use Certification.  If you are no longer able to attend both sessions, please withdraw from the training by emailing [email protected].  This program is approved for up to 5.0 continuing education contact hour(s) by the Alcohol and Drug Abuse Division (#ADAD-24-812) and by the National Association of Social Workers – Hawaiʻi Chapter (NASWHI-CEP-005) for up to 5.0 Social Work continuing education contact hour(s).   This training is co-sponsored by: About the Trainer: Beth Rutkowski, MPH Director of Training, UCLA ISAP/Co-Director, PSATTC Beth Rutkowski, MPH, has been associated with UCLA Integrated Substance Abuse Programs (ISAP) since December 2000, and currently serves as the Director of Training and Co-Director of the SAMHSA-funded Pacific Southwest Addiction Technology Transfer Center. The majority of Ms. Rutkowski’s time is focused on the development of synchronous and asynchronous training and intensive technical assistance activities and products and based on evidence-based substance use disorder research and targeted to the community at large. In addition, she organizes and conducts conferences and trainings throughout the Pacific Southwest region (HHS Region 9, covering AZ, CA, HI, NV, and the six U.S. Affiliated Pacific Jurisdictions) on scientifically validated interventions and topics. Ms. Rutkowski has co-authored and edited several peer reviewed research articles, book chapters, special issues, and technical reports on a variety of topics related to the treatment of substance use disorders.

This webinar will review the pharmacological characteristics of stimulant medications and also medications that provide a stimulant effect and review which medications are most effective in enhancing natural recovery and improving fatigue and cognitive functioning in TBI survivors. A discussion regarding the similarity of ADHD symptoms to TBI symptoms will be presented. Frontal lobe and temporal lobe syndromes will be described, and specific medications will be reviewed that are likely to have a positive impact on the TBI survivor.  Case studies will also be presented exemplifying the complexity of brain injury, cognitive impairment and effective use of medications. Learning Objectives:               Review the definitions, similarities and differences between Stimulant medications             Describe the symptoms of TBI following or during rehabilitation             Differentiate levels of TBI cognitive severity             Understand the Psychopharmacology of Stimulant Medications             Describe atypical stimulants, non-stimulants and antidepressants             Understand the complexity of choosing a stimulant medication in a patient with TBI   Presenter Information Dr. Sparadeo began his career as the Director of the Mayor’s Task Force on Substance Abuse in the City of Providence, R.I. and he was also the Director of Substance Abuse Services for the Providence Mental Health Center at that same time.  After creating a system of clinical services for the City of Providence he was appointed as CEO of Talbot House.  Talbot House was the largest residential substance abuse treatment facility in New England.  Dr. Sparadeo then completed his doctoral studies with a residency at the Boston V.A. Medical Center followed by a 2-year fellowship at Brown University and Rhode Island Hospital (RIH).  The focus of his clinical training was neuropsychology and chronic pain.  He completed his fellowship and was appointed to the Brown University School of Medicine faculty and the Rhode Island Hospital medical staff in the position of Director of Rehabilitation Psychology.  Dr. Sparadeo trained numerous interns and fellows at Brown University.  As Director of Rehabilitation Psychology, Dr. Sparadeo created the first comprehensive outpatient rehabilitation program for survivors of traumatic brain injury.  After 8 years in his position at RIH Dr. Sparadeo was appointed National Director of Substance Abuse and TBI rehabilitation services at New Medico Health Systems in Boston, Massachusetts.  He created inpatient substance abuse treatment programs in 8 rehabilitation facilities throughout the U.S.  He returned to RIH and Brown University to become the director of the Concussion Care Center in the Emergency Department at RIH.  He was also the chief clinical consultant to the Trauma Center and Stepdown Unit, and he was the co-director of the Interdisciplinary Spine Center in the Neurosurgery Department at RIH for 5 years before opening a private practice specializing in the neuropsychological assessment, pain assessment and pain management.  He developed a specialized substance abuse treatment program for people with both TBI and substance abuse.  Eventually, he developed a specialized treatment program for people with chronic pain and opiate addiction.  Over the many years of his career Dr. Sparadeo has been a consultant to many agencies and healthcare programs throughout the U.S.  He has also served on numerous boards of directors.  He was the founder and president of the Brain Injury Association of Rhode Island.  He was also the Chairman of the Governor’s Permanent Advisory Commission on TBI.  He was also a member of the national committee on substance abuse and disability at SAMHSA in Washington, D.C.  Most recently, Dr. Sparadeo has been a consultant and chief trainer on a federally funded grant at the Massachusetts Rehabilitation Commission.  Dr. Sparadeo’s career has also included the publication of many scientific papers and book chapters, and he has been on the faculty of Salve Regina University graduate program in Rehabilitation Counseling where he teaches the Neuroscience of Substance Abuse and Mental Illness, Psychopharmacology for Counselors and the Neuroscience of Opioid Abuse. This training is a collaboration between Mid-America ATTC, Mountain Plains ATTC, and NASHIA. 

  The Great Lakes ATTC offers this training SUD professionals in HHS Region 5: IL, IN, MI, MN, Oh, an WI. This training is offered in response to a need identified by Region 5 stakeholder       DESCRIPTION This three-hour stimulant training, developed by the ATTC Network Stimulant Work Group, presents an overview of stimulant drug use and current treatment options. The presentation includes information on how stimulants affect the brain and body and data on national and regional trends in stimulant use.   LEARNING OBJECTIVES: Understand national and regional trends in stimulant use Understand the impact of stimulants use on the brain and body Understand current best practices in treatment for stimulant use disorders.   Continuing Education: 3 NAADAC CE hours will be available to participants who attend the session in full.     TRAINER Mat Roosa, LCSW-M Mat Roosa was a founding member of NIATx and has been a NIATx coach for a wide range of projects. He works as a consultant in the areas of quality improvement, organizational development, and planning, evidence-based practice implementation.  

ToT for the ATTC Stimulant Package Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches for Effective Treatment and Recovery

The New England ATTC, in partnership with AdCare Educational Institute of New England is hosting this session at the Virtual New England Summer School on 6/8/21 from 10:30am to 3:45pm with subject matter expert Taylor D'Addario. The purpose of this training is to provide information about central nervous system stimulants and their impact on brain, body, and behavior. Specific topics include (1) the scope of stimulant use in the US and beyond; (2) stimulants and the brain and impact of use on cognition; (3) stimulant use and psychosis; (4) short- and long-term physical and mental health consequences of stimulant use and considerations for unique populations; (5) the intersection of stimulant use and HIV risk; and (6) effective evidence-based behavioral treatment interventions and recovery supports for people with a stimulant use disorder.

The New England ATTC in partnership with the Connecticut Department of Mental Health and Addictions Services is hosting the Stimulants and their Impact on Brain and Behavior training on 11/3/21 and 11/10/21 from 9:00-12:00 (EST).  The purpose of this introductory level training is to provide information about central nervous system stimulants and their impact on brain, body, and behavior.  Specific topics include (1) the scope of stimulant use in the US and beyond; (2) impact of stimulants on cognition; (3) stimulant use and psychosis; (4) short- and long-term physical and mental health consequences of stimulant use and considerations for unique populations; (5) the intersection of stimulant use and HIV risk; and (6) effective evidence-based behavioral treatment interventions and recovery supports for people with a stimulant use disorder. [This event is private and by invitation only] 

Please join us for our TOR Webinar: Stimulants and their Effects on Brain Chemistry. We will be featuring our special guest speakers: Dr. Melinda Campopiano and Pam Baston! RESCHEDULED Time: May 26st, from 1-2:30pm CST Questions? Email [email protected].

[This is Part 1 of a 2-Part Training Series Taking Place on 2/17/22 and 2/24/22] The New England ATTC in partnership with the Connecticut Department of Mental Health and Addictions Services is hosting the Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches training on 2/17/22 and 2/24/22 from 9:00-12:00 (EST) with subject matter expert Taylor D'Addario. The purpose of this training is to provide information about central nervous system stimulants and their impact on brain, body, and behavior. Specific topics include (1) the scope of stimulant use in the United States and beyond; (2) stimulants and the brain and impact of use on cognition; (3) stimulant use and psychosis; (4) short- and long-term physical and mental health consequences of stimulant use and considerations for unique populations; (5) the intersection of stimulant use and HIV risk; and (6) effective evidence-based behavioral treatment interventions and recovery supports for people with a stimulant use disorder. [This event is private and by invitation only]

[This is Part 2 of a 2-Part Training Series Taking Place on 2/17/22 and 2/24/22] The New England ATTC in partnership with the Connecticut Department of Mental Health and Addictions Services is hosting the Stimulants and their Impact on Brain and Behavior: Best Practices and Approaches training on 2/17/22 and 2/24/22 from 9:00-12:00 (EST) with subject matter expert Taylor D'Addario. The purpose of this training is to provide information about central nervous system stimulants and their impact on brain, body, and behavior. Specific topics include (1) the scope of stimulant use in the United States and beyond; (2) stimulants and the brain and impact of use on cognition; (3) stimulant use and psychosis; (4) short- and long-term physical and mental health consequences of stimulant use and considerations for unique populations; (5) the intersection of stimulant use and HIV risk; and (6) effective evidence-based behavioral treatment interventions and recovery supports for people with a stimulant use disorder. [This event is private and by invitation only]